• Consensus Rating: Buy
  • Consensus Price Target: $579.00
  • Forecasted Upside: 21.19 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$477.77
▼ -3.15 (-0.65%)

This chart shows the closing price for CHE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Chemed Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHE

Analyst Price Target is $579.00
▲ +21.19% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Chemed in the last 3 months. The average price target is $579.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 21.19% upside from the last price of $477.77.

This chart shows the closing price for CHE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Chemed. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/4/2022Royal Bank of CanadaLower Price TargetOutperform$609.00 ➝ $579.00Low
7/29/2021Royal Bank of CanadaBoost Price TargetOutperform$604.00 ➝ $609.00Low
2/25/2021OppenheimerLower Price TargetOutperform$600.00 ➝ $580.00High
3/10/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$448.00 ➝ $535.00Low
2/19/2020OppenheimerBoost Price TargetOutperform$525.00 ➝ $535.00High
11/25/2019OppenheimerBoost Price TargetMarket Perform$440.00 ➝ $470.00Low
11/1/2019JMP SecuritiesUpgradeMarket Perform ➝ Outperform$490.00High
9/6/2019Bank of AmericaBoost Price TargetBuy$470.00 ➝ $500.00Low
8/1/2019OppenheimerBoost Price TargetOutperform$400.00 ➝ $430.00Low
7/29/2019Royal Bank of CanadaBoost Price TargetSector Perform$405.00Low
4/30/2019OppenheimerBoost Price TargetOutperform$340.00 ➝ $370.00Medium
2/25/2019Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$313.00 ➝ $318.00Low
10/12/2018Bank of AmericaInitiated CoverageBuy$390.00Low
7/30/2018Royal Bank of CanadaBoost Price TargetMarket Perform$321.00Medium
2/16/2018OppenheimerBoost Price TargetOutperform$270.00 ➝ $275.00Low
2/16/2018Royal Bank of CanadaReiterated RatingHold$258.00Low
10/31/2017Royal Bank of CanadaBoost Price TargetPositive ➝ Sector Perform$232.00N/A
10/27/2017OppenheimerBoost Price TargetOutperform$220.00 ➝ $225.00N/A
10/27/2017KeyCorpReiterated RatingHoldN/A
10/3/2017Royal Bank of CanadaReiterated RatingHold$209.00Low
9/1/2017Royal Bank of CanadaReiterated RatingHold$209.00N/A
8/28/2017KeyCorpInitiated CoverageSector Weight ➝ Sector WeightLow
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight ➝ Outperform Market WeightN/A
7/31/2017Royal Bank of CanadaReiterated RatingHold$209.00Low
7/27/2017OppenheimerBoost Price TargetOutperform$200.00 ➝ $220.00Medium
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
12/7/2021
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
1/6/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/5/2022
  • 4 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 6 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2022
  • 6 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 6 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Chemed logo
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Read More

Today's Range

Now: $477.77
Low: $472.65
High: $480.50

50 Day Range

MA: $481.24
Low: $437.63
High: $505.68

52 Week Range

Now: $477.77
Low: $403.00
High: $539.87

Volume

68,030 shs

Average Volume

61,849 shs

Market Capitalization

$7.15 billion

P/E Ratio

27.96

Dividend Yield

0.30%

Beta

0.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Chemed?

The following equities research analysts have issued research reports on Chemed in the last twelve months: Royal Bank of Canada, and StockNews.com.
View the latest analyst ratings for CHE.

What is the current price target for Chemed?

0 Wall Street analysts have set twelve-month price targets for Chemed in the last year. Their average twelve-month price target is $579.00, suggesting a possible upside of 21.2%.
View the latest price targets for CHE.

What is the current consensus analyst rating for Chemed?

Chemed currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CHE will outperform the market and that investors should add to their positions of Chemed.
View the latest ratings for CHE.

How do I contact Chemed's investor relations team?

Chemed's physical mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company's listed phone number is (513) 762-6690. The official website for Chemed is www.chemed.com. Learn More about contacing Chemed investor relations.